We observed that NaBu treatment caused a significant downregulation of CAIX (p < 0.01, n = 3) expression and the expression of the colon cancer stem cell marker CD133 (p < 0.05, n = 3) (Figure S9). The gene discussed is CA9; the disease is malignant colon neoplasm.